1,4-Dioxa-8-azaspiro(4.5)decane → 8-(5-Methoxypyridin-3-yl)-1,4-dioxa-8-azaspiro[4.5]decane

HRID 454

반응식

HRID 454 반응식
C1CC2(CCN1)OCCO2.COc1cncc(Br)c1>CC(=O)O.CC(=O)O.CC(C)(C)[O-].CC(C)c1cc(C(C)C)c(-c2ccccc2P(C2CCCCC2)C2CCCCC2)c(C(C)C)c1.Cc1ccccc1.[Na+].[Pd]>COc1cncc(N2CCC3(CC2)OCCO3)c1

참가 물질

7

반응 조건

온도
100 °C

실험 절차

11/05 2011 07:58:54 +0200 A mixture of 3-bromo-5-methoxypyridine (1.5 g, 7.98 mmol), 1,4-dioxa-8-azaspiro[4.5]decane (1.023 ml, 7.98 mmol), palladium(II) acetate (0.107 g, 0.48 mmol) and dicyclohexyl(2',4',6'-triisopropylbiphenyl-2-yl)phosphine (0.228 g, 0.48 mmol) in toluene (38.3 ml) and tBuOH (7.65 ml) was evacuated and flashed with N2 several times. Then sodium 2-methylpropan-2-olate (0.920 g, 9.57 mmol) was added and the reaction mixture was heated to 100°C for 2hrs. LCMS showed complete conversion. Reaction mixture had turned black. The reaction mixture was filtered through celite. The celite was washed with DCM. The combined filtrates were concentrated to yield 2.2g of brown oil, which starts to crystalise patially. Crude NMR showed only little unreacted amine (ca. 14%). The crude was purified by flash: The residue was purified by automated flash chromatography on a 100g column. A gradient from 40% to 100% of EA in Hep over 12CV, 100% EA over 6CV was used as mobile phase. The product was collected using the wavelength 254 nm. 1.5g of desired product were obtained as a light yellow oil.

출처 및 근거

ORD 기록
ord-7ce32a5d4abb4826b07e10a8720e8cf8
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

연결된 노트

불러오는 중…